ACTICOR

Welcome to the Brand page for “ACTICOR”, which is offered here for In the statement, classes 1 and 42 have been corrected per the restriction dated 12/10/20, and per the fnote dated 1/26/2021.;antibodies in the form of biological preparations for the prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases; pharmaceuticals for prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases; pharmaceutical preparations and substances prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases;monoclonal antibodies for scientific use; [ reagents for scientific or medical research use; biochemicals for in vitro and in vivo scientific use and medical research use; ] biological preparations * of monoclonal antibodies * for use in industry and science [ ; proteins in raw material form for use in scientific research ];[ medical and scientific laboratory services relating to the production of antibodies; ] biotechnological and pharmaceutical drug development services; pharmaceutical and biotechnological research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields;.

Its status is currently believed to be active. Its class is unavailable. “ACTICOR” is believed to be currently owned by “ACTICOR BIOTECH”.